Researchers developed a bifunctional Cu2O/BiOCl nano-heterojunction that enables both sensitive electrochemical detection and visible-light degradation of 4-aminophenol. While not a drug in itself, the platform advances the broader toolbox of hybrid inorganic materials that can combine sensing and remediation behaviors. Additionally, a study introduced spider silk particles modified with a new DM4R2 variant to improve colloidal stability and drug affinity for carrier applications. The work reported loading efficiencies up to 90% for methotrexate and lysozyme with no cytotoxicity in tested assays. Taken together, these findings reflect ongoing progress in biomaterials for biomedical use cases—where stability, binding strength, and functional performance are increasingly treated as design constraints rather than post-processing challenges.